Back to all assets

MetLife MET

equity

Price History

$14.76$42.06$69.36$96.66
2000-04 · DCA start$14.76

Time underwater

How far below its previous all-time high the price sat, each month. 0% means a new high.

-73.5%-49.0%-24.5%0.0%
2000-042026-08 · 0.0%

Worst drawdown: −74%, peaking Sep 2007 and bottoming Feb 2009 — 163 months below the prior high before recovering.

DCA Backtest

Invested
$31,700
Value today
$76,877
Return
+142.5%
Months invested
317

Scenarios

Inflation — the same contributions merely keeping pace with CPI would be $46,055 today, so the real (inflation-adjusted) return is +66.9%.

Lump sum instead — $31,700 all at once in Apr 2000: $207,574 (+554.8%) — lump sum came out ahead.

Worst timing — same monthly amount started at the all-time high (Jul 2026): $200.55 on $200 invested (+0.3%).

⚠ Price returns only — dividends are not included. This understates the true return of dividend-paying shares, and any comparison against crypto (which pays no dividends) is biased against equities by roughly the dividend yield, compounded.

If this saved you a spreadsheet — buy me a coffee.

Every start month at once

Each cell is the return-to-date of £/$/€100-a-month DCA started that month. Click a cell to load it in the backtest above. The ringed cell is the all-time-high start — the worst timing scenario.

JFMAMJJASOND
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Legend:−50%−20%0%+50%+200%+1000%worst timing (ATH)Selected 2000-04: +142.5%

About MetLife

MetLife, Inc. is the holding corporation for the Metropolitan Life Insurance Company (MLIC), better known as MetLife, and its affiliates. MetLife is among the largest global providers of insurance, annuities, and employee benefit programs, with around 90 million customers in over 60 countries. The firm was founded on March 24, 1868. MetLife ranked No. 43 in the 2018 Fortune 500 list of the largest United States corporations by total revenue. (Wikipedia)

It's a listed company categorised under financials and life & health insurance, with a market cap of about $61.4B.

It rates Medium-High Risk at 2.6/5, meaning real but ordinary risk — the kind most mainstream assets carry, with some factors scoring poorly.

What pushes the score up: earnings quality (5.0/5) and sector / regulatory (4.0/5).

Scoring well: leverage / financial at 1.0/5.

Not yet researched: concentration, governance. These are excluded from the score rather than guessed, so the real risk may be higher than what’s shown.

Ratings summarise sourced facts against fixed rules — not investment advice, and no substitute for your own diligence.

Risk Profile

Medium-High Risk(2.6/5)80% rated

How these ratings work

Market / Volatility3.0/5 · weight 20%
  • Annualised volatility (3yr)2/519.7
  • Max drawdown from ATH4/573.5
  • Beta vs S&P 5003/51.3
Liquidity1.0/5 · weight 15%
  • Avg daily $ volume1/5330.2m
  • Float % of shares outstandingnot yet researched
Leverage / Financial1.0/5 · weight 20%
  • Debt / equitynot yet researched
  • Interest coverage (EBIT / interest)1/58.5
Earnings Quality5.0/5 · weight 15%
  • 3yr EPS volatility5/5176
Concentrationunrated · weight 10%
  • Largest customer, % of revenuenot yet researched
  • Geographic revenue concentrationnot yet researched
Governanceunrated · weight 10%
  • Board independence %not yet researched
  • Share structurenot yet researched
  • Litigation / audit historynot yet researched
Sector / Regulatory4.0/5 · weight 10%
  • Sector regulatory exposure4/5high

Linked Assets

Same sector, or return-correlated — worth knowing what else might move if this one does.